Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SinuSurf in healthy subjects
NCT02728505Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sinusurf in rhinosinusitis, sponsored by Vanderbilt University Medical Center. Primary endpoint: University of Pennsylvania Smell Identification Test at 5 weeks. Started Apr 2016; status: completed.
02
Drugs
sinusurf
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on NCT02728505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728505.